Saitama, Japan

Tatsuhiko Seki

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Atom Medical Corporation. Active years: 2002-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuhiko Seki. Retrieved from https://idiyas.com/inventor/tatsuhiko-seki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Honjo, JP (2006)
  • Saitama, JP (2002 - 2021)

Company Filing History:


Years Active: 2002-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tatsuhiko Seki: Pioneering Inventor from Saitama, JP

Introduction: Tatsuhiko Seki is a renowned inventor hailing from Saitama, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tatsuhiko Seki holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Tatsuhiko Seki has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the realm of invention.

Collaborations: Throughout his career, Tatsuhiko Seki has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Tatsuhiko Seki's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…